Table 2. Neutralizing antibody response elicited in Chinese rhesus macaques immunized with SIVsmE660 gp145 and SIVmac251 gp140 at various weeks after immunization.
Animal ID | Bleed week | Neutralization titres ID50 (ID80) | ||||
---|---|---|---|---|---|---|
Tier 1A | Tier 1B | Tier 2 | ||||
SIVmac251.6 | SIVsmE660-BR/CG7G.IR1 | SIVmac251/M766 | SIVsmE660-BR/CG7V.IR | SIVmac251.30 | ||
M907* | 0 | <20 | <20 (<20) | <20 (<20) | <20 (<20) | <20 (<20) |
20 | 5428 (<20) | 29 170 (6735) | <20 (<20) | <20 (<20) | <20 (<20) | |
42 | 9354 (<20) | >43 740 (12 545) | <20 (<20) | 2672 (<20) | <20 (<20) | |
M908 | 0 | <20 (<20) | <20 (<20) | <20 (<20) | <20 (<20) | <20 (<20) |
20 | 2726 (<20) | >43 740 (26 104) | 41 (<20) | 7259 (<20) | <20 (<20) | |
42 | 3572 (<20) | >43 740 (12 300) | 26 (<20) | 5570 (<20) | <20 (<20) | |
83 (DOC) | 26 129 (49) | >43 740 (26 294) | 3664 (24) | 5374 (<20) | 118 (<20) | |
84 | 15 236 (<20) | >43 740 (24 171) | <20 (<20) | 7082 (<20) | <20 (<20) | |
85 | 8794 (<20) | >43 740 (15 850) | <20 (<20) | 3862 (<20) | <20 (<20) | |
M909 | 0 | <20 (<20) | <20 (<20) | <20 (<20) | <20 (<20) | <20 (<20) |
20 | 2542 (<20) | 8125 (1927) | <20 (<20) | <20 (<20) | <20 (<20) | |
42 | 4437 (28) | 9189 (2476) | <20 (<20) | <20 (<20) | <20 (<20) | |
83 (DOC) | 22 974 (122) | >43 740 (12 651) | 4672 (23) | 1203 (<20) | 144 (<20) | |
84 | 16 409 (<20) | 29 822 (5179) | <20 (<20) | <20 (<20) | <20 (<20) | |
M910 | 0 | <20 (<20) | <20 (<20) | <20 (<20) | <20 (<20) | <20 (<20) |
20 | 5377 (<20) | 34 428 (5758) | <20 (<20) | 2431 (<20) | <20 (<20) | |
42 | 5626 (<20) | 34 792 (5935) | <20 (<20) | <20 (<20) | <20 (<20) | |
83 (DOC) | 8478 (105) | >43 740 (15 459) | 44 (25) | 1881 (<20) | 56 (<20) | |
84 | 7556 (<20) | >43 740 (18 489) | <20 (<20) | <20 (<20) | <20 (<20) |
Data are displayed in a heat map with shades of grey indicating higher nuetralizing antibody titre.
▪ 40–100, ▪ 100–1000, ▪ >1000.
*Animal was euthanized before challenge due to non-vaccine related issues.